id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-4703-0008,FDA,FDA-2015-E-4703,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2019-03-08T05:00:00Z,2019,3,2019-03-08T05:00:00Z,,2019-03-08T13:02:49Z,,0,0,0900006483acc8d3
FDA-2015-E-4703-0007,FDA,FDA-2015-E-4703,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ESBRIET",Notice,Determinations,2018-02-22T05:00:00Z,2018,2,2018-02-22T05:00:00Z,2018-04-24T03:59:59Z,2018-02-22T19:29:17Z,2018-03612,0,0,0900006482f53b51
FDA-2015-E-4703-0006,FDA,FDA-2015-E-4703,Regulatory Review Letter,Other,Letter(s),2017-05-12T04:00:00Z,2017,5,2017-05-12T04:00:00Z,,2017-05-12T22:08:12Z,,0,0,09000064825aff33
FDA-2015-E-4703-0005,FDA,FDA-2015-E-4703,Letter from CDER to U.S. Patent and Trademark Office,Other,Letter(s),2017-05-12T04:00:00Z,2017,5,2017-05-12T04:00:00Z,,2017-05-12T18:29:13Z,,0,0,09000064825ae03b
FDA-2015-E-4703-0004,FDA,FDA-2015-E-4703,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:28:26Z,,0,0,0900006482434369
FDA-2015-E-4703-0003,FDA,FDA-2015-E-4703,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-01-26T05:00:00Z,2016,1,2016-01-26T05:00:00Z,,2016-01-26T13:45:25Z,,0,0,0900006481e252df
FDA-2015-E-4703-0001,FDA,FDA-2015-E-4703,"Patent Extension Application from Marshall, Gerstein & Borun, LLP ( on behalf of InterMune, Inc.)",Other,Application,2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,,2015-12-10T13:37:24Z,,0,0,0900006481d932e4
FDA-2015-E-4703-0002,FDA,FDA-2015-E-4703,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,,2015-12-09T16:57:09Z,,0,0,0900006481d932e6